To help all industry stakeholders keep abreast of the latest developments and gain insight into market trends of new cosmetic ingredients, CIRS Group has systematically compiled and in-depth analyzed the September 2026 new cosmetic ingredient filing information published by the National Medical Products Administration (NMPA). The following report mainly covers the number of new ingredient filings during the month, the basic profile and regional distribution of the notifiers, and ingredient interpretation, striving to provide the industry with valuable data support and information.

I. Number of New Cosmetic Ingredient Filings in China in September 2026

According to queries of the National Medical Products Administration (NMPA), a total of 12 new cosmetic ingredients completed filing in September 2026. The relevant technical requirements have not yet been disclosed, and none has entered the monitoring period. Details are shown in Table 1 below. Compared with the same period last year (12 filings in September 2025), the filing volume remained flat year-on-year. As of the end of September 2026, a cumulative total of 151 new cosmetic ingredients had been filed in 2026.

Table 1

Note: The English names of the companies listed above are for reference only. Please refer to the official registered or commonly used names for formal use.

II. Overview of Enterprises Filing for New Cosmetic Ingredients

(I) Domestic and Overseas Distribution of Enterprises Filing for New Ingredients

As shown in Figure 1, among the 12 new cosmetic ingredients that obtained filing numbers in September 2026, the notifiers of 10 ingredients are located in mainland China, accounting for about 83.3%; the notifiers of 2 ingredients are located overseas, accounting for about 16.7%. The number of domestic notifiers far exceeds that of overseas notifiers.

Figure 1

(II) Domestic Enterprises

According to the analysis of the filing data, among the above 12 new cosmetic ingredients, 10 were filed by Chinese domestic enterprises, involving 10 different companies, with each company filing 1 new ingredient.

(III) Enterprise Outside Chinese Mainland

The notifiers of 2 new cosmetic ingredients are located in overseas countries and regions, involving a total of 2 overseas companies.

III. Distribution of Enterprises Filing for New Cosmetic Ingredients by Province/Region

(I) Domestic Enterprises

According to the analysis of the filing data, 10 new ingredients were filed by companies in mainland China, involving 10 companies distributed across 7 provinces and regions, namely Guangdong, Shanghai, Guizhou, Jilin, Shandong, Yunnan and Zhejiang. As shown in Figure 2, among all the provinces where domestic notifiers are located, Guangdong obtained the largest number of new ingredient filing numbers, with 3.

Figure 2

(II) Enterprise Outside Chinese Mainland

As shown in Figure 3, 2 new ingredients were filed by overseas companies, and the 2 overseas notifiers involved are from Japan and the United States, respectively, with each country having 1 notifier company that obtained 1 filing number.

Figure 3

IV. Interpretation of Selected Ingredients

According to queries, shikimic acid is a naturally occurring chiral compound with biological activity. Natural shikimic acid is mainly extracted from the dried fruits of Illicium verum (star anise). Studies have shown that shikimic acid affects arachidonic acid metabolism, inhibits platelet aggregation, and inhibits the formation of arterial, venous and cerebral thrombosis; it also has anti-inflammatory and analgesic effects, and can be used as an intermediate for antiviral and anticancer drugs.

Camellia chekiangoleosa is a plant of the genus Camellia in the family Theaceae, distributed in Fujian, Jiangxi, Hunan, Zhejiang and Anhui of China, and is a tree species endemic to China.

Chimonanthus praecox is a deciduous shrub of the genus Chimonanthus in the family Calycanthaceae, also known by various names such as wintersweet, yellow plum flower, wax wood, golden plum, fragrant plum and dried-branch plum. It is native to China and is widely cultivated throughout the country. As recorded in the Bencao Gangmu (Compendium of Materia Medica) written by Li Shizhen of the Ming Dynasty, Chimonanthus praecox can relieve summer heat and promote fluid production, stimulate the appetite and relieve depression, detoxify and promote tissue regeneration, and regulate qi and relieve cough; it can also be used for summer-heat damaging body fluids, dizziness and vomiting, epigastric and abdominal distension, chest tightness and cough, as well as burns and scalds. Beyond being an ornamental plant, its flowers contain various aromatic substances such as linalool, borneol, eucalyptol, pinene and sesquiterpene alcohols, and are among the fragrant flowers used to make premium scented tea.

Pandanus amaryllifolius is an evergreen herbaceous plant of the genus Pandanus in the family Pandanaceae, commonly known as pandan leaf or fragrant pandan, and is prized for its aromatic leaves. Native to Southeast Asia, it is also cultivated in Hainan and other areas of China. Its leaves are widely used in cooking, adding flavor to rice, desserts such as pandan cake, and beverages. In addition, Pandanus amaryllifolius has excellent application value and development prospects in relevant medical products and cosmetics.

Global CosIng, independently developed by CIRS Group, serves as a one-stop search tool for global cosmetic compliance information. You can visit Global CosIng and find out more via the following link: https://globalcosing.chemradar.com/.

What Can CIRS Do for You?

Established in 2007, the CIRS Group is a leading product safety and regulatory consulting firm. CIRS has branch offices in the Republic of Ireland, South Korea, the United States, the United Kingdom, Japan, and China. CIRS Group utilizes its technical expertise, various resources, and international network to provide one-stop compliance services, from regulatory compliance, laboratory testing, and R&D to data services across multiple industries. 

The CIRS cosmetic team provides expert support to ensure that cosmetic products meet stringent global cosmetic regulations and safety standards. We offer comprehensive, lifecycle-based solutions for personal care products, from early-stage cosmetic ingredient development through to final product registration. Our services include:

• Cosmetic ingredient development and regulatory strategy,
• Physical/chemical and analytical tests, 
• Toxicological tests (in vivo & in vitro),
• Efficacy and claim substantiation studies (in vivo & in vitro), and
• Ingredient and product registration across global markets.

With deep expertise in cosmetic regulatory compliance and safety evaluations, our team enables brands to bring products to market efficiently and with confidence.

Our Services 

• China Cosmetics Registration and Filing
• China New Cosmetic Ingredients Registration and Filing
• China Toothpaste Filing
• Cosmetics Safety Test
• Cosmetics Efficacy Claims Test
• Micrological analysis
• Physicochemical Analysis
• Being a Domestic Responsible Person
• Safety Assessment Report
• Cosmetic Ingredient Quality and Safety Info Code Application
• Formula/Label/Ingredient Review
• Regulatory Consulting/Reporting/Training
• Custom Clearance

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.